Bio Pharmaceutics Classification System (BCS) Class IV Drug Nanoparticles: Quantum Leap to Improve Their Therapeutic Index
Purpose: Biopharmaceutics classification system (BCS) class IV compounds, exhibits least oral bioavailability, low solubility and intestinal permeability among all pharmaceutical classes of drugs. Thus, these drugs need more compatible and efficient delivery system. Since, their solubility in variou...
Saved in:
Main Authors: | Sachin Kumar (Author), Ramneek Kaur (Author), Rashi Rajput (Author), Manisha Singh (Author) |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preeclampsia after the Seven Quantum Leap Prediction
by: Johanes C Mose
Published: (2019) -
Pediatric Biopharmaceutical Classification Systems (pBCS)
by: Justyna Srebro, et al.
Published: (2023) -
Lipid nanoparticles: A challenging approach for oral delivery of BCS Class-II drugs
by: Ganesan Poovi, et al.
Published: (2018) -
BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of Furosemide
by: Milica Markovic, et al.
Published: (2020) -
Study of the effect of active pharmaceutical ingredients of various classes of BCS on the parameters of thermosensitive systems based on poloxamers
by: E.O. Bakhrushina, et al.
Published: (2023)